• 208 pages • 42 Exhibits • 15 Company Profiles • Report #V201 · Published February 2016
This report is a market analysis of products and technologies used for peripheral arterial and venous stenting. First introduced about two decades ago as a bailout technique for suboptimal or failed iliac angioplasty, peripheral vascular stenting gradually emerged as a valuable and versatile tool for a variety of primary and adjuvant applications outside the domain of coronary and cerebral vasculature. Today, peripheral vascular stenting techniques are commonly employed in the management of the most prevalent occlusive circulatory disorders and other pathologies affecting the abdominal and thoracic aortic tree and lower extremity arterial bed. Stents are also increasingly used in the management of the debilitating conditions like venous outflow obstruction associated with deep venous thrombosis and chronic venous insufficiency.
The report provides full year (actual) 2014 caseload and procdure volume data, market size and share data, with forecast market data to 2020, for the U.S., Western Europe, Asia/Pacific, and Rest of World, for peripheral applications of bare metal stents, drug-eluting stents, thoracic and abdominal aortic aneurysm stents, and peripheral venous stents.
See the table of contents and list of exhibits at link.
MedMarket Diligence Reports are produced through primary and secondary research. Primary research includes interviews with clinicians, industry representatives, and other stakeholders in the market for their knowledge and insights on product development, market development, clinical practice and trends associated with the evolving use of technologies. Secondary data includes SEC filings; company annual reports; regional, federal, and international datasets; brokerage other investment reports; and other independent market research is used to corroborate and support assessments and projections. Reports are written and researched by industry insiders, whose familiarity with the companies, industry dynamics and other marketplace specifics facilitate the research process and ensure high quality and thorough reports.
For immediate download, orderonline or fax yourorder form.
Reports library access is also available through annual contract.
Refund Policy: MedMarket Diligence print products are refundable if returned in salable condition within 30 (thirty) days of purchase date. Electronic products (PDF, online database subscription) are non-refundable; clients are urged to review content on mediligence.com or contact MedMarket Diligence directly via phone or email in advance of purchase to ensure that electronic products will meet customer needs.